Your shopping cart is currently empty

Emlenoflast sodium (MCC7840 sodium), a sulfonylurea, is a selective NLRP3 inflammasome inhibitor with an IC50 value of less than 100 nM for NLRP3 inflammasome, and can be used in the study of inflammatory diseases.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | Inquiry | 5 days | 5 days | |
| 5 mg | $970 | 5 days | 5 days | |
| 25 mg | Inquiry | 6-8 weeks | 6-8 weeks | |
| 50 mg | Inquiry | 6-8 weeks | 6-8 weeks | |
| 100 mg | Inquiry | 6-8 weeks | 6-8 weeks |
| Description | Emlenoflast sodium (MCC7840 sodium), a sulfonylurea, is a selective NLRP3 inflammasome inhibitor with an IC50 value of less than 100 nM for NLRP3 inflammasome, and can be used in the study of inflammatory diseases. |
| Targets&IC50 | NLRP3 inflammasome:<100 nM |
| In vitro | Emlenoflast sodium is an MCC950 analogue that exhibits useful activity in inhibiting NLRP3 inflammasome activation with IC50 <100 nM.[1] |
| In vivo | Emlenoflast sodium (4 mg/kg; i.v.; Male C57BL/6 mice) showed t1/2=3.39 h; AUC0-last=107097 ng•h/mL; CL=0.621 mL /min/kg.[2] Emlenoflast sodium (20 mg/kg; p.o.; Male C57BL/6 mice) exhibits good oral bioavailability (67.2%), Cmax (60467 ng/mL) and half-life (5.02 h) in mice.[2] |
| Synonyms | MCC7840 sodium |
| Molecular Weight | 411.47 |
| Formula | C19H24N4NaO3S |
| Cas No. | 2380032-29-9 |
| Smiles | [Na].O=C(NC=1C2=C(C=C3C1CCC3)CCC2)NS(=O)(=O)C4=NN(C=C4)C(C)C |
| Storage | Powder: -20°C for 3 years | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 216 mg/mL (524.95 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 5 mg/mL (12.15 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.